PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial Results
PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial Results Nachrichtenquelle: globenewswire | 13.05.2021, 13:00 | 43 | 0 FLORHAM PARK, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune T-cell activating technology, will discuss its financial resu...
Source: wallstreet-online.de